Key facts
- Somnee’s last known valuation is $39.0M (Dec 2022).
- It has raised $24.3M; the latest was Seed Round ($10.0M) in Sep 2025.
- Notable investors include Khosla Ventures, Gaingels, Nelstone Ventures, 10X Capital, Devos Group — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Somnee
- ·The full record, as it builds
Funding rounds
No funding rounds for Somnee are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Somnee
Developer of a diagnostic and therapeutic wearable technology designed to improve sleep quality and efficiency and create better sleep through neuroscience. The company's system uses multi-modal brain stimulation that is personalized for individuals to give efficacious improvements to the sleep cycle, enabling customers to improve memory and cognitive performance.
- Sector
- Healthcare
- HQ
- Berkeley, CA, United States
- Founded
- 2017
- Employees
- 14
- Website
- somneesleep.com/
- Ownership
- Privately Held (backing)
Somnee doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Somnee shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Somnee in its N-PORT filings yet. We sweep new filings monthly.